Schonfeld Strategic Advisors LLC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 173 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$3,642,596
+30.8%
38,900
+24.7%
0.03%
+16.7%
Q2 2023$2,784,600
+24.3%
31,200
+49.3%
0.02%
+14.3%
Q1 2023$2,240,898
-73.0%
20,900
-69.2%
0.02%
-69.6%
Q4 2022$8,287,498
+417.6%
67,858
+337.8%
0.07%
+430.8%
Q3 2022$1,601,000
-7.0%
15,500
+21.1%
0.01%
-18.8%
Q4 2021$1,722,000
-5.8%
12,800
-7.9%
0.02%
-15.8%
Q2 2021$1,828,000
+75.1%
13,900
+71.6%
0.02%
+46.2%
Q1 2021$1,044,000
-74.6%
8,100
-67.1%
0.01%
-76.4%
Q4 2020$4,106,000
-4.7%
24,620
-11.8%
0.06%
-32.9%
Q3 2020$4,308,000
+0.5%
27,915
-3.7%
0.08%
+43.9%
Q2 2020$4,288,000
+170.4%
29,000
+154.4%
0.06%
+46.2%
Q4 2019$1,586,000
-58.6%
11,400
-71.4%
0.04%
-65.5%
Q3 2019$3,834,000
-63.6%
39,800
-56.5%
0.11%
-69.7%
Q2 2019$10,536,000
-51.5%
91,500
-50.4%
0.37%
-50.5%
Q1 2019$21,705,000
+2077.0%
184,400
+1129.3%
0.75%
+1296.3%
Q2 2018$997,000
+181.6%
15,000
+53.6%
0.05%
+68.8%
Q3 2017$354,0009,7630.03%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q2 2021
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders